Bio Pharma Dive
JANUARY 10, 2025
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is one of several announced by high-ranking FDA leaders ahead of the coming administration change.
Pharmaceutical Technology
JANUARY 10, 2025
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
JANUARY 10, 2025
The FDA has granted clearance to Heidelberg Engineerings Epithelial Thickness Module (ETM) integrated into the companys Cornea App, which is a part of the Anterion ocular imaging platform. The new module is expected to enhance precision in corneal health assessment, offering ophthalmologists a robust tool for more comprehensive and accurate evaluation of the corneal epithelium.
Bio Pharma Dive
JANUARY 10, 2025
The CRISPR gene editing company will reduce its workforce by 27% over the course of the year as it discontinues a treatment for alpha-1 antitrypsin deficiency.
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.
XTalks
JANUARY 10, 2025
Zhengye Biotechnology Holding Limited, a China-based veterinary vaccine manufacturer, closed its initial public offering (IPO) on January 8, 2025, raising $6 million. Specializing in vaccines for livestock such as swine, cattle, dogs and poultry, Zhengye has been a key player in Chinas veterinary vaccine market for over 20 years and began trading on the Nasdaq under the ticker symbol “ZYBT.” Current Share Price: The veterinary vaccines market is expected to exceed $16 billion by 2030
Bio Pharma Dive
JANUARY 10, 2025
“Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers now being tested in inflammatory conditions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
JANUARY 10, 2025
Sasanlimab, a subcutaneous immunotherapy developed by Pfizer, could help treat bladder cancer. Elsewhere, Royalty Pharma moved to simplify its corporate structure and Biogen made another hire.
Pharmaceutical Technology
JANUARY 10, 2025
GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimers disease in 2033.
Medical Xpress
JANUARY 10, 2025
Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by University of Pittsburgh School of Medicine and UPMC surgeon-scientists and published today in the Journal of Thrombosis and Haemostasis.
Pharmaceutical Technology
JANUARY 10, 2025
Climb Bio has entered an exclusive licence agreement with Beijing Mabworks Biotech for developing and commercialising CLYM116.
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
pharmaphorum
JANUARY 10, 2025
Ouro launches today with $120m in funding and a plan to develop bispecific antibody-based T cell engagers for autoimmune diseases.
Pharmaceutical Technology
JANUARY 10, 2025
Coave has raised 32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.
Medical Xpress
JANUARY 10, 2025
A new tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating Trichuris trichiura and other soil-transmitted helminths (STH), according to a clinical trial conducted by the STOP consortium and led by the Barcelona Institute of Global Health (ISGlobal).
Pharmaceutical Technology
JANUARY 10, 2025
A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T cell therapies for solid tumour cancers.
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
Medical Xpress
JANUARY 10, 2025
Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer patients will respond to chemotherapy and antibody-directed cancer treatments.
Pharmaceutical Technology
JANUARY 10, 2025
Newron and Myung In Pharm have signed a licence agreement for evenamide, for schizophrenia treatment in South Korea.
pharmaphorum
JANUARY 10, 2025
An AI algorithm can help detect REM sleep behaviour disorder, which affects millions of people and is a warning signal for neurological diseases.
Medical Xpress
JANUARY 10, 2025
As the U.S. Supreme Court considers whether Congress can ban TikTok, new research highlights the health risks that top social media platforms pose to children.
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
pharmaphorum
JANUARY 10, 2025
Eyeing a first commercial launch in 2027, Intellia is re-prioritising by cutting 27% of its workforce and shelving a lung disease candidate.
Medical Xpress
JANUARY 10, 2025
Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may seem universal, the reality is that there are nuances that require individual attention, both in the make-up of the patients being seen and the situations of the hospitals providing their care.
pharmaphorum
JANUARY 10, 2025
Discover how the AI tool SearchGPT is revolutionising the pharma and healthcare industries, providing advanced search capabilities and insights for professionals in medical research and practice.
Medical Xpress
JANUARY 10, 2025
There may be a link between hearing impairment and an increased risk of developing Parkinson's according to research led by Lancaster University.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
pharmaphorum
JANUARY 10, 2025
Improving health literacy is essential for patient understanding and better health outcomes. Learn three effective ways to enhance health literacy and empower patients.
Medical Xpress
JANUARY 10, 2025
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer drugs compared to others on Traditional Medicare.
pharmaphorum
JANUARY 10, 2025
Stay tuned for live coverage of JP Morgan Week 2025 provided by pharmaphorum. Get the latest insights and updates on this important event in the pharmaceutical industry.
Medical Xpress
JANUARY 10, 2025
A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JANUARY 10, 2025
A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today.
Medical Xpress
JANUARY 10, 2025
Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century have received that approval based on their ability to target genetic changes driving tumor growth.
Pharmaceutical Commerce
JANUARY 10, 2025
The collaboration is powered by the discovery and development of obesity, type 2 diabetes, and cardiovascular disease treatments.
Medical Xpress
JANUARY 10, 2025
Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.
Expert insights. Personalized for you.
292 
Let's personalize your content